SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $508,639 | +10.8% | 4,196 | +4.6% | 0.09% | +12.7% |
| Q2 2023 | $459,225 | -8.5% | 4,010 | +10.2% | 0.08% | -8.1% |
| Q1 2023 | $501,701 | -2.9% | 3,640 | -8.7% | 0.09% | -8.5% |
| Q4 2022 | $516,506 | +16.6% | 3,986 | -0.6% | 0.09% | +2.2% |
| Q3 2022 | $443,000 | +47.7% | 4,011 | -54.9% | 0.09% | -42.5% |
| Q2 2017 | $300,000 | +14.1% | 8,887 | 0.0% | 0.16% | +20.3% |
| Q1 2017 | $263,000 | +7.8% | 8,887 | 0.0% | 0.13% | -0.7% |
| Q4 2016 | $244,000 | -55.0% | 8,887 | 0.0% | 0.13% | -52.7% |
| Q3 2016 | $542,000 | +101.5% | 8,887 | -30.9% | 0.28% | +93.8% |
| Q2 2016 | $269,000 | -44.5% | 12,862 | -48.3% | 0.15% | -41.4% |
| Q1 2016 | $485,000 | -47.3% | 24,862 | +4.2% | 0.25% | -50.3% |
| Q4 2015 | $921,000 | – | 23,862 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |